Practice Management
Kids who have irritable bowel syndrome with constipation (IBS-C) now have a new treatment option as the Food and Drug Administration (FDA) this month approved linaclotide for pediatric patients 7 years and older. There is no known underlying cause for IBS-C in children, and symptoms include chronic constipation and abdominal pain. Linaclotide is the first treatment approved for IBS-C in pediatric patients with a recommended dose of 145 mcg orally once daily. A 12-week, double-blind, …
Read More
Urgent message: Constipation can be a sign of serious – even life-threatening – etiologies. Once non-benign causes have been ruled out, emphasis should be on evacuation and dietary and lifestyle changes to prevent recurrence. Claire West, MD, Samuel M. Keim, MD, MS, and Peter Rosen, MD Introduction Constipation is a common complaint, accounting for approximately 2.5 million doctor visits annually. With increasing difficulty in obtaining a quick appointment with a primary care physician, more and …
Read More